Regulation of Viral Infection by the RNA Modification N6-Methyladenosine
- PMID: 31283446
- PMCID: PMC6884077
- DOI: 10.1146/annurev-virology-092818-015559
Regulation of Viral Infection by the RNA Modification N6-Methyladenosine
Abstract
In recent years, the RNA modification N6-methyladenosine (m6A) has been found to play a role in the life cycles of numerous viruses and also in the cellular response to viral infection. m6A has emerged as a regulator of many fundamental aspects of RNA biology. Here, we highlight recent advances in techniques for the study of m6A, as well as advances in our understanding of the cellular machinery that controls the addition, removal, recognition, and functions of m6A. We then summarize the many newly discovered roles of m6A during viral infection, including how it regulates innate and adaptive immune responses to infection. Overall, the goals of this review are to summarize the roles of m6A on both cellular and viral RNAs and to describe future directions for uncovering new functions of m6A during infection.
Keywords: DNA viruses; N6-methyladenosine; RNA modifications; RNA viruses; innate immunity; m6A; post-transcriptional regulation.
Figures


Similar articles
-
Nonsegmented Negative-Sense RNA Viruses Utilize N6-Methyladenosine (m6A) as a Common Strategy To Evade Host Innate Immunity.J Virol. 2021 Apr 12;95(9):e01939-20. doi: 10.1128/JVI.01939-20. Print 2021 Apr 12. J Virol. 2021. PMID: 33536170 Free PMC article.
-
Emerging Perspectives of RNA N6-methyladenosine (m6A) Modification on Immunity and Autoimmune Diseases.Front Immunol. 2021 Mar 5;12:630358. doi: 10.3389/fimmu.2021.630358. eCollection 2021. Front Immunol. 2021. PMID: 33746967 Free PMC article. Review.
-
Methyltransferase-like 3 Modulates Severe Acute Respiratory Syndrome Coronavirus-2 RNA N6-Methyladenosine Modification and Replication.mBio. 2021 Aug 31;12(4):e0106721. doi: 10.1128/mBio.01067-21. Epub 2021 Jul 6. mBio. 2021. PMID: 34225491 Free PMC article.
-
Association of N6-methyladenosine with viruses and related diseases.Virol J. 2019 Nov 11;16(1):133. doi: 10.1186/s12985-019-1236-3. Virol J. 2019. PMID: 31711514 Free PMC article. Review.
-
RNA N6-Methyladenosine Modifications and the Immune Response.J Immunol Res. 2020 Jan 21;2020:6327614. doi: 10.1155/2020/6327614. eCollection 2020. J Immunol Res. 2020. PMID: 32411802 Free PMC article. Review.
Cited by
-
WTAP Targets the METTL3 m6A-Methyltransferase Complex to Cytoplasmic Hepatitis C Virus RNA to Regulate Infection.J Virol. 2022 Nov 23;96(22):e0099722. doi: 10.1128/jvi.00997-22. Epub 2022 Oct 31. J Virol. 2022. PMID: 36314819 Free PMC article.
-
N6-methyladenosine RNA modification promotes viral genomic RNA stability and infection.Nat Commun. 2022 Nov 2;13(1):6576. doi: 10.1038/s41467-022-34362-x. Nat Commun. 2022. PMID: 36323720 Free PMC article.
-
METTL3 from Target Validation to the First Small-Molecule Inhibitors: A Medicinal Chemistry Journey.J Med Chem. 2023 Feb 9;66(3):1654-1677. doi: 10.1021/acs.jmedchem.2c01601. Epub 2023 Jan 24. J Med Chem. 2023. PMID: 36692498 Free PMC article. Review.
-
Methyltransferase-like (METTL)14-mediated N6-methyladenosine modification modulates retinal pigment epithelial (RPE) activity by regulating the methylation of microtubule-associated protein (MAP)2.Bioengineered. 2022 Mar;13(3):4773-4785. doi: 10.1080/21655979.2022.2032968. Bioengineered. 2022. PMID: 35139773 Free PMC article.
-
Regulation of m6A Methylation as a New Therapeutic Option against COVID-19.Pharmaceuticals (Basel). 2021 Nov 8;14(11):1135. doi: 10.3390/ph14111135. Pharmaceuticals (Basel). 2021. PMID: 34832917 Free PMC article.
References
-
- Carpenter S, Ricci EP, Mercier BC, Moore MJ, Fitzgerald KA. 2014. Post-transcriptional regulation of gene expression in innate immunity. Nat. Rev. Immunol 14:361–76 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources